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Abstract Surfactant preparations obtained from porcine lungs
by extraction with chloroform/methanol followed by chroma-
tography over Lipidex-5000 are used for treatment of respiratory
distress syndrome in preterm infants. These preparations contain
about 98% phospholipids and 1^2% of the hydrophobic
pulmonary surfactant-associated proteins B and C (SP-B and
SP-C). Separation of the proteins in the surfactant preparation
by reversed-phase high performance liquid chromatography
revealed, in addition to SP-B and SP-C, the presence of three
peptides derived from the cathelicidin family of antibacterial
peptides. The 79-residue proline-rich peptide prophenin (identical
to that isolated from leukocytes), an 80-residue prophenin with
an N-terminal pyroglutamic acid residue, and a C-terminal 18-
residue fragment of prophenin were found in approximate molar
ratios of 1:20:5. A synthetic version of the C-terminal 18-residue
peptide exhibits salt-dependent antibacterial activity (higher
activity in the absence of salt) against the Gram-positive
bacterium Bacillus megaterium Bm11 and, to a lesser extent,
against Gram-negative Escherichia coli D21 cells. It appears
possible that the presence of prophenin peptides may contribute
to the antibacterial properties of surfactant preparations.
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1. Introduction
Pulmonary surfactant is a heterogeneous mixture of lipids,
mainly phospholipids, and proteins. Surfactant is essential
because it reduces the surface tension of the alveolar liquid
lining, thus preventing lung collapse at end of expiration. In-
su⁄cient amounts of surfactant in preterm neonates give rise
to respiratory distress syndrome (RDS), a potentially lethal
disease. In addition, surfactant contributes to the lung host
defence. Four surfactant proteins have been described to date
[1]. Surfactant proteins A and D (SP-A and SP-D) are collag-
enous lectins (collectins) which are thought to participate
primarily in the lung host defence. SP-A knock-out mice have
essentially normal respiratory function but are more suscep-
tible to pulmonary infections than wild-type mice [2,3]. SP-B
and SP-C on the other hand, are probably primarily involved
in the reduction of alveolar surface tension. Children with
genetic de¢ciency of SP-B and SP-B knock-out mice develop
severe respiratory distress at birth [4,5]. SP-B and SP-C are
structurally unrelated but are both strictly hydrophobic and
associated with surfactant phospholipids. Surfactant prepara-
tions obtained from animal lungs by extraction and chroma-
tography in organic solvents contain phospholipids, SP-B and
SP-C, but not SP-A and SP-D, and are used in the treatment
of RDS in premature infants. Instillation of such surfactant
preparations give bacteriostatic e¡ects in an animal model of
pulmonary infection [6].
Improved methods for the isolation and analysis of pulmo-
nary surfactant constituents have recently been introduced.
High resolution separation of SP-B, SP-C and isoforms there-
of is achieved with reversed-phase high performance liquid
chromatography (RP-HPLC) employing gradient elution
with aqueous ethanol or methanol and isopropanol [7]. Lip-
id-associated proteins and phospholipids can be largely sepa-
rated by chromatography over Lipidex-5000 in ethylene chlo-
ride/methanol 1:4 (v/v) [8]. We have now employed these
methods to resolve the proteins present in organic extracts
of porcine lung homogenates and ¢nd that the antibacterial
protein prophenin and a fragment thereof are present in such
extracts. Prophenin is likewise present in clinically used sur-
factant preparations obtained from porcine lungs.
2. Materials and methods
2.1. Organic extraction of lung tissue
Two alternative ways were employed for tissue homogenization. In
the ¢rst method 100 g of minced lung tissue was homogenized in 400
ml of chloroform/methanol 1:1 (v/v), whereafter 100 ml of water was
added. After ¢ltration and addition of 50 ml of chloroform, the ho-
mogenate was phase separated and the lower organic phase was col-
lected and evaporated to dryness. In the second method [9] minced
lung tissue was initially washed with saline and the mixture was ¢l-
tered. Cells and debris were removed by centrifugation at 1000Ug for
15 min at 20‡C, and the supernatant was subsequently centrifuged at
3000Ug for 2 h at 4‡C. The pellet was then extracted with chloro-
form/methanol 2:1 (v/v) [9].
2.2. Puri¢cation of proteins present in organic lung extracts
The dried organic extracts were resolubilized in ethylene chloride/
methanol 1:4 (v/v) and separated by reversed-phase chromatography
on a 40U6.5 cm Lipidex-5000 column in the same solvent system. The
protein and phospholipid contents of the eluate were monitored by
phenylthiocarbamyl amino acid analysis and phosphorus determina-
tion, respectively. The protein fractions elute between 35 and 50% of
one column volume, while phospholipids start eluting at about 45%
[8]. Protein-containing fractions were collected, pooled, and further
resolved by gel-¢ltration over Sephadex LH-60 in chloroform/metha-
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nol/0.1 M HCl, 19:19:2 (by vol), or in chloroform/methanol/water,
19:19:2 (by vol). Proteins eluting between 15 and 60% of one column
volume (corresponding to the elution positions of SP-B and SP-C)
were collected.
Samples of Curosurf (which are obtained by Lipidex-5000 chroma-
tography of organic extracts of minced and saline-washed porcine
lungs) were dissolved in chloroform/methanol 1:1 (v/v) and protein-
containing fractions were isolated by Sephadex LH-60 chromatogra-
phy as above.
Sephadex LH-60 fractions were evaporated to dryness, redissolved
in ethanol and analyzed by RP-HPLC using a C18 column (Vydac,
250U4.6 mm), with a £ow of 0.7 ml/min, 60% methanol (aq)/0.1%
tri£uoroacetic acid (TFA) as the initial solvent and elution with a
linear gradient of 2-propanol/0.1% TFA [7].
2.3. Protein analysis
For tryptic digestion, 100 Wg of prophenin isolated from lung tissue
as above was dissolved in 0.1 M ammonium bicarbonate, pH 8.0, 1 Wg
of trypsin was added, and the mixture was incubated for 4 h at 37‡C,
whereafter proteolysis was halted by addition of acetic acid to 1%
(v/v).
For matrix-assisted laser desorption/ionization time-of-£ight
(MALDI-TOF) mass spectrometry, peptides (20^50 ng) were dried
on a stainless-steel grid together with approximately 5 Wg K-cyano-
4-hydroxycinnamic acid. Molecular masses were determined with a
Finnigan MAT Lasermat 2000 instrument (Hemelhensted, England),
operated in the positive ion mode. Calibration was performed with
glucagon (average mass [M+H] = 3482.8) and LL-37 (average mass
[M+H] = 4493.3).
Nano-electrospray (nano-ES) mass spectra were recorded on an
AutoSpec orthogonal acceleration time-of-£ight focal plane detector
(OATOFFPD) (Micromass, Manchester, England) high resolution
tandem mass spectrometer [10]. This instrument consists of a double
focusing arrangement of electric (E) and magnetic (B) sectors as mass
spectrometer 1 (MS1) and an orthogonal acceleration time-of-£ight
(OATOF) mass analyzer as MS2. Samples were introduced by nano-
ES from gold coated borosilicate capillaries. The ion source was op-
erated at a potential of 4 kV in the positive ion mode. For the record-
ing of conventional mass spectra the instrument was tuned to a
resolution of approximately 3000 (10% valley de¢nition) and the mag-
net scanned at a rate of 15 s/decade over m/z ranges 100 (or 400)
to 3000. High resolution (10 000, 10% valley de¢nition) spectra
were recorded as voltage scans over m/z ranges just su⁄cient to
bracket sample peaks between calibrant ion peaks. Tandem mass
spectra were recorded by selecting the precursor ion of interest using
MS1, decelerating the ions to 400 eV and focusing them into a colli-
sion cell containing methane collision gas at a pressure su⁄cient to
attenuate the precursor ion beam by about 80%. Undissociated pre-
cursor ions and fragment ions formed by collision induced dissocia-
tion (CID) were orthogonally accelerated into the time-of-£ight mass
analyzer.
Amino acid sequence analysis was carried out with an Applied
Biosystems 494 Prosice protein sequencer with on-line HPLC separa-
tion of released phenylthiohydantoin derivatives.
2.4. Antibacterial activity
An inhibition zone assay in 1 mm agarose plates seeded with Es-
cherichia coli D21 or Bacillus megaterium Bm11 cells was used [11].
Bacteria were grown overnight on agar plates containing 100 Wg/ml
streptomycin and were then inoculated in Luria-Bertani (LB) medium.
Bacteria were added to 1% (mass/vol) agarose in LB medium, LB
medium without NaCl, or LB broth containing medium E (0.8 mM
MgSO4, 9.6 mM citric acid, 57.4 mM K2HPO4 and 16.7 mM
NaNH4HPO4) to a concentration of 6U104 cells/ml just before plat-
ing. Small wells (3 mm diameter, 3 Wl volume) were punched out of
the plates and prophenin, isolated from lung tissue, was added dis-
solved in 0.1% TFA. After overnight incubation at 30‡C, the diame-
ters of the inhibition zones were determined. To study the antibacte-
rial activity of the amidated C-terminal 18-residue fragment
encompassing positions 62^79 of prophenin-1, this fragment was syn-
thesized (Interactiva, Germany), since we were unable to separate the
naturally occurring fragment from the full-length prophenins (see Sec-
tion 3). The synthetic peptide was puri¢ed by RP-HPLC and analyzed
by MALDI-TOF (expected molecular mass 2044.5 Da, calculated
molecular mass 2044.4 Da).
3. Results
3.1. Identi¢cation of prophenin in organic extracts of porcine
lung
Proteins in chloroform/methanol extracts of lung tissue
were separated from most of the lipids by Lipidex-5000 chro-
matography and thereafter size-fractionated by Sephadex LH-
60 chromatography. RP-HPLC of the Sephadex LH-60 frac-
tion eluting between 25 and 35% of the column volume, i.e.
the elution position of SP-B [9], revealed one peak that elutes
at about 35% 2-propanol, a second peak at about 60%
2-propanol and a group of peaks eluting at about 80^90%
2-propanol (Fig. 1). SP-B and SP-C are known to elute at
about 60 and 90^100% 2-propanol, respectively, under these
conditions [7]. Consistent with this, MALDI-TOF analysis of
the peptide eluting at 60% 2-propanol showed peaks corre-
sponding to singly and multiply protonated forms of SP-B.
The molecular mass of SP-B determined from these peaks is
17 440 Da, which is in good agreement with the calculated
molecular mass of SP-B of 17 446 Da. The small peak at
93% 2-propanol (Fig. 1) corresponds to SP-C, as determined
by MALDI-TOF analysis (experimental average mass 4218
Da, calculated average mass of methylated and methionine
oxidized SP-C 4217 Da) and amino acid analysis. The other
peaks in the group of late eluting compounds (Fig. 1) are non-
peptide components as determined by amino acid analysis,
and probably represent traces of phospholipids.
MALDI-TOF analysis of the early eluting HPLC peak in
Fig. 1 revealed two peptides. One peptide produces [M+H]
ions at m/z 8746 (i.e. corresponding to a molecular mass of
8745 Da), while the other peptide gives [M+H] ions at m/z
2044 (corresponding to a molecular mass of 2043 Da). The
relative abundance of the two sets of ions varied between
Fig. 1. Reversed-phase HPLC of lipopeptides from porcine lung tis-
sue. HPLC resolution of proteins from organic extracts of porcine
lung tissue, puri¢ed by Lipidex-5000 chromatography and by gel-
¢ltration over Sephadex LH-60 (elution between 25 and 35% of one
column volume). A C18 stationary phase and a linear gradient of
2-propanol/0.1% TFA running into 60% methanol (aq.)/0.1% TFA
were employed for RP-HPLC.
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di¡erent experiments, but in most cases both sets could be
detected. Attempts to separate the two peptides by HPLC
for individual analysis were not successful. Amino acid se-
quence analysis of the peptides in the early HPLC peak
yielded two sequences, which could be individually assigned
because of their di¡erent amounts (Fig. 2). Sequence #1 in
Fig. 2 corresponds exactly to the N-terminal sequence of the
antibacterial cathelicidin peptide prophenin, which is a 79-
residue polypeptide originally puri¢ed from porcine leuko-
cytes [12]. An Val/Phe isomorphism at prophenin position
17 exists [13], but no evidence for the Phe-17 prophenin
form was found in the present study. The molecular mass of
8745 Da found by MALDI-TOF analysis is 113 Da higher
than expected from the prophenin amino acid sequence con-
taining Val-17, and where the C-terminus is amidated (theo-
retical average mass 8632 Da). Sequence #2 in Fig. 2 corre-
sponds to prophenin positions 62^78. The calculated average
mass of prophenin position 62^79 with a C-terminal amide is
2043 Da, thus in excellent agreement with the experimental
molecular mass. Therefore, it is concluded that the peptide
isolated corresponds to prophenin position 62^79 with a C-
terminal amide, and the C-terminal residue escaped detection
by sequence analysis. The molar ratio of 79-residue prophenin
and the 18-residue fragment, as estimated from yields of ami-
no acid derivatives during sequence analysis, was about 1:5.
The full-length prophenin and its C-terminal peptide were
found in organic extracts of homogenized whole lung, as well
as in extracts of saline-washed minced lungs. In the former
case the ratio of the areas of HPLC peaks for prophenin and
SP-B was about 3:1 (Fig. 1), while in the latter case the ratio
was about 1:1. Likewise, analysis of Curosurf preparations
revealed the presence of full-length prophenin and the peptide
corresponding to prophenin position 62^79, in an approxi-
mate ratio of 1:1 compared to SP-B. In contrast, no HPLC
peak corresponding to prophenin could be detected in organic
extracts of porcine bronchoalveolar lavage £uid.
3.2. Prophenin-2 is N-terminally elongated with pyroglutamic
acid
In order to resolve the reason for the discrepancy between
the molecular mass calculated from the amino acid sequence
and that determined by MALDI-TOF mass spectrometry (see
above) we analyzed prophenin by nano-ES mass spectrome-
try. The molecular mass of prophenin was determined to be
8744 Da (Fig. 3), which is 111 Da greater than the theoretical
mass of prophenin with Val-17 and a C-terminal carboxylic
acid (average mass 8633 Da), or 112 Da greater than the
theoretical mass of prophenin with Val-17 and a C-terminal
amide (average mass 8632 Da). Small amounts of unmodi¢ed
prophenin (average mass 8633 Da) were also detected. The
molecular masses of prophenin measured by nano-ES above
were to an accuracy of þ 1 Da. Thus, as it was not known
whether the C-terminal is actually amidated or not, the exact
magnitude of the modi¢cation (111 or 112 Da) was not un-
equivocally determined. In an attempt to resolve this question,
Fig. 2. Identi¢cation of prophenin in surfactant preparations. Re-
sults of amino acid sequence analysis of proteins eluting under the
HPLC peak at 35% 2-propanol in Fig. 1. X denotes a position
where no amino acid could be unequivocally assigned.
Fig. 3. Nano-ES mass spectrum of prophenin isolated from porcine lung tissue. The top spectrum shows the multiprotonated forms of the pro-
tein i.e. [M+6H]6-[M+11H]11. After maximum entropy treatment the lower spectrum of the uncharged protein was attained.
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prophenin was cleaved with trypsin and the tryptic fragments
analyzed by high resolution nano-ES mass spectrometry. A
tryptic fragment was observed with a monoisotopic mass of
1258.6504 Da which agrees to within 3.6 ppm (0.0046 Da)
with the mass of the N-terminal tryptic fragment (T1, cleaved
C-terminally of Arg-11, see Fig. 2) modi¢ed with a pyroglu-
tamic acid residue (pyroGlu, mass 111.0320 Da). Only a very
minor unmodi¢ed T1 fragment was observed. The location of
this proposed pyroglutamic residue in tryptic fragment T1 was
con¢rmed by tandem mass spectrometry. Shown in Fig. 4 is
the CID spectrum of the [M+2H]2 ion of m/z 630.3 which
corresponds to the doubly protonated T1 fragment modi¢ed
with pyroGlu. Series of y9 -y

4 and y
2
10 -y
2
7 fragment ions lo-
cate the modi¢cation to the N-terminus. This is con¢rmed by
a minor series of b1 -b

5 fragment ions. The presence of the
pyroGlu modi¢cation is further con¢rmed by the observation
of its characteristic ammonium ion at m/z 84 (Fig. 4).
We conclude that prophenin now isolated from lung lip-
oproteins, as well as prophenin previously isolated from leu-
kocytes [12], consists of a mixture of two full-length polypep-
tides. One form is the 79-residue polypeptide with Ala as N-
terminal residue, previously referred to as prophenin-1 [12]
(this form was now detected by sequence analysis ; Fig. 2).
The second prophenin form has 80 residues with an extra
N-terminal pyroGlu compared to prophenin-1 (this form
was now observed by mass spectrometry but not by sequence
analysis as it is refractory to Edman degradation). The latter
polypeptide corresponds to prophenin-2, the covalent struc-
ture of which has not been previously resolved [12]. The ratio
between prophenin-1 and prophenin-2, estimated from ES
mass spectrometry, is approximately 1:20.
3.3. Antibacterial activity of prophenins isolated from lung
tissue by organic extraction and a synthetic 18-residue
fragment corresponding to prophenin-1 (positions 62^79)
The isolated prophenin peptides, which constitute a mixture
of prophenin-1 and prophenin-2 and the C-terminal 18-resi-
due fragment in approximate molar ratios of 1:20:5 were
Fig. 4. Identi¢cation of pyroglutamic acid in prophenin-2. CID spectrum of the [M+2H]2 ion of m/z 630.3, which corresponds to the doubly
protonated T1 fragment modi¢ed with pyroGlu. The fragmentation nomenclature is from Roepstor¡ and Fohlman [24], modi¢ed by Biemann
[25]. The y-ions are identi¢ed in the mass spectrum. The minor b-ions were all detectable at closer inspection of the mass spectrum, but are
not identi¢ed in the spectrum. Pyr, pyroglutamic acid. A, P, F, and Pyr identify the peaks that represent ammonium ions derived from the re-
spective amino acid.
Fig. 5. Antibacterial activity of the prophenin C-terminal 18-residue
fragment. Inhibition zone assay of the activity of a synthetic 18-resi-
due peptide corresponding to positions 62^79 of prophenin-1 against
B. megaterium Bm11 and E. coli D21 cells, in the presence of di¡er-
ent salt solutions. The diameter2 of the inhibition zones is plotted
against the peptide concentration applied. Filled symbols, activity
against B. megaterium in LB medium without sodium chloride (dia-
monds), LB medium (squares) and medium E (triangles). Open sym-
bols, activity against E. coli in LB medium without sodium chloride.
No activity against E. coli was detected in LB medium and in me-
dium E.
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tested for antibacterial activity against E. coli D21 and
B. megaterium Bm11 cells using an inhibition zone assay.
This showed antibacterial activity against B. megaterium
grown in salt-free LB medium (6 mm inhibition zones) at a
total peptide concentration of 0.5 Wg/Wl. In the presence of
150 mM NaCl in the growth medium, no activity was de-
tected. The isolated prophenins showed no activity against
E. coli.
The synthetic C-terminal fragment exhibited dose-depend-
ent antibacterial activity at concentrationss 10 Wg/Wl. It was
more active against B. megaterium Bm11 than against E. coli
D21, and the activity increased with decreasing salt concen-
tration (Fig. 5).
4. Discussion
Organic extracts of porcine lung tissue puri¢ed by chroma-
tography over Lipidex-5000 and Sephadex LH-60 contain 79-
residue prophenin (previously referred to as prophenin-1), 80-
residue pyroGlu-prophenin (previously referred to as proph-
enin-2) and a C-terminal 18-residue fragment of prophenin.
This is an unexpected ¢nding since SP-B and SP-C have been
considered to be the exclusive proteins in such preparations.
Prophenin has so far only been isolated from porcine leuko-
cytes and in aqueous media [12].
Elastase can liberate the mature antibacterial peptides from
the cathelicidin precursors by cleavage C-terminally of a spe-
ci¢c Val residue, as shown for bovine proBac5 and proBac7
[14] and porcine proprotegrin [15]. Cleavage after the corre-
sponding Val in the prophenin precursor (Val-128, [16]) would
generate a 97-residue long polypeptide, which indicates that
the isolated prophenin-1 and -2 are generated either by multi-
ple processing steps or are formed without cleavage after Val-
128. The identi¢cation of the 80-residue prophenin-2 suggests
that proteolytic release from the precursor is mediated by
cleavage between the dibasic Arg-Arg pair at positions 144^
145 and Gln-146, and the latter subsequently cyclises and
forms the N-terminal pyroGlu of prophenin-2. Cleavage after
paired basic residues is a common feature in the biosynthesis
of peptide hormones [17], although hormones and other bio-
active peptides are also generated by cleavages at other sites
[18]. The 79-residue prophenin-1 is likely formed from the
initially liberated 80-residue prophenin by aminopeptidase ac-
tivity, similar to the proposed processing of the human cath-
elicidin antibacterial peptide LL-37 [19].
In addition to full-length prophenins a fragment consisting
of prophenin-1 residues 62^79, i.e. covering the C-terminal 18
residues was found in all preparations analyzed. This frag-
ment has not been found previously. Our results also showed
that this fragment is active against both B. megaterium Bm11
and E. coli D21, although only at comparatively high concen-
trations. Since this fragment was found in organic extracts of
homogenized whole lung and saline-extracted minced lungs
now prepared, as well as in Curosurf, it appears likely that
it constitutes a naturally occurring fragment. Harwig and
coworkers found that a fragment of prophenin covering posi-
tion 42 to nearby the C-terminus, generated by trypsin cleav-
age, retained partial microbicidal activity against E. coli, while
fragments covering positions 1^41 were inactive [12]. Together
these results suggest that the C-terminal part of prophenin
may be of importance for its antibacterial function.
Prophenin copuri¢es with surfactant phospholipids and the
polypeptides SP-B and SP-C during extraction and Lipidex-
5000 chromatography in organic solvents. Prophenin and the
C-terminal fragment were also detected in Curosurf, a surfac-
tant preparation which is obtained from minced porcine lungs
by organic extraction and Lipidex-5000 chromatography [20]
and is used for treatment of RDS in premature infants. It is
thus conceivable that prophenin is associated with pulmonary
surfactant in vivo, but it can not be excluded that prophenin
associates with surfactant components after being released
from other sources upon tissue homogenization. The latter
possibility would be compatible with the fact that prophenin
could not be detected in bronchoalveolar lavage surfactant.
However, prophenin was detected also when minced lung tis-
sue was extracted with saline and centrifuged in order to re-
move cells prior to organic extraction, although at a lower
yield relative to SP-B compared to after organic extraction
of whole tissue homogenates. These results may suggest that
prophenin now found is not derived only from leukocytes.
Notably, LL-37 is present in bronchoalveolar lavage £uid
[21] and lung epithelium [22]. Furthermore, short acidic pep-
tides with antibacterial activity have been found in ovine sur-
factant [23]. Maybe antibacterial peptides associated with sur-
factant form a constitutive line of defence against invading
pathogens.
Prophenin now isolated in organic solvents exhibits antibac-
terial activity against the Gram-positive bacterium B. mega-
terium, provided that sodium chloride is omitted from the
growth medium. Unlike prophenin isolated from leukocytes
by size exclusion chromatography and RP-HPLC in aqueous
solvents [12] no activity against E. coli was found for proph-
enin-1 and -2 isolated in organic solvents. Whether this di¡er-
ence is caused by the di¡erent bacterial strains used and/or the
di¡erent isolation procedures cannot be unequivocally deter-
mined from the present data. However, also the C-terminal
18-residue fragment, which was puri¢ed in aqueous media, is
more active against B. megaterium than E. coli. This argues
against the isolation in organic solvents as a primary cause of
the observed di¡erences. Pulmonary surfactant preparations
from porcine lungs (Curosurf) exhibit bacteriostatic e¡ects
against group B streptococci [6]. It is tempting to speculate
that this activity, at least in part, is caused by the presence of
antibacterially active prophenin and/or fragments thereof in
such preparations.
In summary we have found that prophenin, a cathelicidin
peptide with antibacterial properties, is present in organic ex-
tracts of porcine lung and in a surfactant preparation which is
used for treatment of RDS in premature infants. Additionally,
a previously unknown 18-residue fragment of prophenin was
found in the same preparations. We also explain the existence
of two prophenin isoforms as being caused by the presence
(prophenin-2) and absence (prophenin-1), respectively, of an
N-terminal pyroglutamic acid.
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